CClaimWatch
Claims closedsecurities

Celgene Corporation Securities Litigation Settlement

This settlement is closed to new claims — the deadline was April 13, 2026. You can still see what it was about and follow the case in court below. Looking for money you can still claim? Browse open settlements →

What happened

Celgene Corporation and officers Terrie Curran and Philippe Martin allegedly violated federal securities laws by making false and misleading statements during the Class Period regarding certain pharmaceutical products and drug candidates including GED-0301, Otezla, and Ozanimod.

Do you qualify?

All persons and entities who purchased Celgene common stock between April 27, 2017 and April 27, 2018 (inclusive) and were damaged thereby. Excluded are defendants, company directors and officers, company affiliates, and their families.

How to file

Submit a Claim Form with required supporting documentation postmarked or submitted online no later than April 13, 2026. The Claim Form is available on the File a Claim page of the settlement website in English and Spanish. Contact the Claims Administrator at 1-855-648-0893, info@CelgeneSecuritiesLitigation.com, or by mail for instructions.

This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.

More securities settlements

View all →